Michael H. Davidson Caladrius Biosciences, Inc. (CLBS) insider trading activity

CLBS Quotes by TradingView

Michael H. Davidson is Director of CALADRIUS BIOSCIENCES, INC.. Currently has a direct ownership of 209,753 shares of CLBS, which is worth approximately $738,330. The most recent transaction as insider was on Jan 10, 2022, when has been sold 65,430 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 210K
0% 3M change
0% 12M change
Total Value Held $738,330

Michael H. Davidson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 10 2022
BUY
Grant, award, or other acquisition
-
65,430 Added 23.78%
209,753 Common Stock
Jan 11 2021
BUY
Grant, award, or other acquisition
-
37,735 Added 20.73%
144,323 Common Stock

Also insider at

TENX
TENAX THERAPEUTICS, INC. Healthcare
NAMS
NewAmsterdam Pharma Co N.V.
Chief Executive Officer
BIOA
BioAge Labs, Inc.
MHD

Michael H. Davidson

Director
Basking Ridge, NJ

Track Institutional and Insider Activities on CLBS

Follow CALADRIUS BIOSCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLBS shares.

Notify only if

Insider Trading

Get notified when an Caladrius Biosciences, Inc. insider buys or sells CLBS shares.

Notify only if

News

Receive news related to CALADRIUS BIOSCIENCES, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CLBS